Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 8
Submit an article Journal homepage
280
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Severe presentations and high mortality from SARS-CoV-2 in patients undergoing chimeric antigen receptor (CAR-T) therapy: a UK NCCP analysis

Kathleen P. L. Cheoka Department of Hematology, University College London, London, UK;b Department of Hematology, University College London Hospital, London, UKView further author information
,
Amy A. Kirkwoodc Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, UKView further author information
,
Tobias Menned Department of Hematology, Freeman Hospital, Newcastle, UKView further author information
,
Eleni Tholoulie Department of Hematology, Manchester Royal Infirmary, Manchester, UKView further author information
,
Sridhar Chagantif Department of Hematology, Queen Elizabeth Hospital, Birmingham, UKView further author information
,
Amrith Mathewf Department of Hematology, Queen Elizabeth Hospital, Birmingham, UKView further author information
,
Ben Uttenthalg Department of Hematology, Addenbrooke’s Hospital, Cambridge, UKView further author information
,
James Russellg Department of Hematology, Addenbrooke’s Hospital, Cambridge, UKView further author information
,
David Irvineh Department of Hematology, Queen Elizabeth University Hospital, Glasgow, UKView further author information
,
Rod Johnsoni Department of Hematology, Leeds Teaching Hospitals NHS Trust, Leeds, UKView further author information
,
Emma Nicholsonj Department of Hematology, Royal Marsden Hospital, London, UKView further author information
,
Jessica Bazinj Department of Hematology, Royal Marsden Hospital, London, UKView further author information
,
William Townsendb Department of Hematology, University College London Hospital, London, UKView further author information
,
Andrea Kuhnlk Department of Hematology, King’s College Hospital, London, UKORCID Iconhttps://orcid.org/0000-0002-4952-2550View further author information
ORCID Icon,
Maeve O’Reillyb Department of Hematology, University College London Hospital, London, UKView further author information
,
Robin Sandersonk Department of Hematology, King’s College Hospital, London, UKView further author information
,
Amit Patell Department of Hematology, Christie Hospital, Manchester, UKView further author information
&
Claire Roddiea Department of Hematology, University College London, London, UK;b Department of Hematology, University College London Hospital, London, UKCorrespondence[email protected]
View further author information
 show all
Pages 1980-1984 | Received 17 Dec 2021, Accepted 19 Mar 2022, Published online: 28 Apr 2022

References

  • Logue JM, Zucchetti E, Bachmeier CA, et al. Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma. Haematologica. 2021;106(4):978–986.
  • Camargo JF, Mendoza MA, Lin R, et al. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy. Trans Infect Dis. 2021;23(4):e13625.
  • Hensley MK, Bain WG, Jacobs J, et al. Intractable COVID-19 and prolonged SARS-CoV-2 replication in a CAR-T-cell therapy recipient: a case study. Clin Infect Dis. 2021;73:e815–e821.
  • Busca A, Salmanton-García J, Corradini P, et al. COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP. Blood Adv. 2021.
  • Clinical management of COVID-19 patients: living guidance, 25 January 2021. [Internet]. [cited 2021 Oct 1]. Available from: https://app.magicapp.org/#/guideline/j1WBYn
  • Anand K, Burns E, Sano D, et al. Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS. J Clin Oncol. 2019;37(15):2540–2540.
  • Cevik M, Tate M, Lloyd O, et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and Meta-analysis. Lancet Microbe. 2021;2(1):e13–e22.
  • Shah V, Ko Ko T, Zuckerman M, et al. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King’s College Hospital experience. Br J Haematol. 2020;190(5):e279–e282.
  • Pérez-Lago L, Aldámiz-Echevarría T, García-Martínez R, et al. Different within-Host viral evolution dynamics in severely immunosuppressed cases with persistent SARS-CoV-2. Biomedicines. 2021;9(7):808.
  • Corey L, Beyrer C, Cohen MS, et al. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385(6):562–566.
  • Basile K, McPhie K, Carter I, et al. Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19. Clin Infect Dis. 2021;73:e2952–e2959.
  • Weinreich DM, Sivapalasingam S, Norton T, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with covid-19. N Engl J Med. 2021;384(3):238–251.
  • Horby PW, Mafham M, Group RC, et al. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;399:665–676.
  • Fox TA, Kirkwood AA, Enfield L, et al. Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID‐19 with B‐cell malignancies. Br J Haematol. 2021;195:706–709.
  • Lim SH, Campbell N, Johnson M, et al. Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma. Lancet Haematol. 2021;8(8):e542–e544.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.